Skip to main content

Fennec Pharmaceuticals Inc.

FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001211583

In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 5 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.

Q1 2024 vs. Q4 2023

How the institutions holding Fennec Pharmaceuticals Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of FENC: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders5665+9
Shares15.0M14.5M−523.1K (−3.5%)
Value$168.4M$161.1M−$7.32M (−4.3%)

New holders (14)

Institutions that held Fennec Pharmaceuticals Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to FENC in Q1 2024
InstitutionSharesValue% of portfolio
Essex Investment Management Co LLC144,218$1.60M0.32%
Renaissance Technologies LLC139,900$1.56M0.00%
Legato Capital Management LLC57,121$635.2K0.08%
Citadel Advisors LLC48,714$541.7K0.00%
Arrowstreet Capital, Limited Partnership39,909$444.0K0.00%
Squarepoint Ops LLC33,694$374.7K0.00%
Jane Street Group, LLC15,554$173.0K0.00%
Cubist Systematic Strategies, LLC10,162$113.0K0.00%
Qube Research & Technologies Ltd8,884$98.8K0.00%
CIBC Private Wealth Group, LLC1,565$17.0K0.00%
Point72 (DIFC) Ltd256$2.85K0.00%
Cornerstone Planning Group LLC66$6100.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC3$330.00%
CWM, LLC8$00.00%

Sold out (5)

Institutions that held Fennec Pharmaceuticals Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of FENC in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Avoro Capital Advisors LLC1,200,000$13.5M
EAM Investors, LLC65,795$738.2K
Mirae Asset Global Investments Co., Ltd.10,398$116.7K
The PNC Financial Services Group, Inc.87$976
Simplex Trading, LLC12$0